Oncomax and Metamax are Prix Galien Russia 2013 Nominees for “Best Research in Russia”

The 2013 Prix Galien Russia ceremony will take place in Moscow on the 24th of October. A jury of eminent specialists involved in the sphere of Russian and international pharmaceutical research will announce the laureates in three categories: Best Research in Russia, Best Pharmaceutical Agent and Best Biopharmaceutical Product.
 
Laureates of three categories will be announced in the presence of the selection committee and influential industry guests. Amongst the prominent figures attending the ceremony are H.E. Veronika Skvortsova, Minister of Health of Russia and H.E. Jean de Gliniasty, Ambassador of France to the Russian Federation. 
 
Oncomax and Metamax are Prix Galien Russia 2013 Nominees for “Best Research in Russia”. Metamax has submitted to Jury’s approval its developed drug MM-D37K for the treatment of colorectal and other gastrointestinal cancer, Oncomax - OM-RCA-01 for treatment of renal cell carcinoma.
 
The Prix Galien Award is considered the biomedical industry’s highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines.
 

 

Anna Sitnikova,
Chief public relations Expert Maxwell Biotech Group;
Tel.: +7 (495) 411-6992
E-mail: sitnikova@maxwellbiotech.ru